loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for NCGC00024623-04? Find Controlled & Modified Release used in NCGC00024623-04 to address drug delivery challenges on PharmaCompass.

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    View Presentation

    High-quality raw materials and custom blends for pharma, biopharma, nutrition, veterinary, and cosmetics worldwide.

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Menu

    NCGC00024623-04

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 235Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1SPI Pharma

    02 5Nanjing Well Pharmaceutical

    03 6Actylis

    04 9BASF

    05 3CD Formulation

    06 4Finar

    07 1Ideal Cures

    08 2Nomisma Healthcare

    09 1Sigachi Industries

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    SPI Pharma

    U.S.A
    arrow
    World Vaccine Congress
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

    Dosage Form : Tablet

    Grade : Oral

    Brand Name : ACTILLETS™

    Application : Coating Systems & Additives, Controlled & Modified Release

    Excipient Details : ACTILLETS are microcrystalline cellulose spheres developed using advanced drug delivery technology to enable effective loading & coating of particles.

    Pharmacopoeia Ref : NA

    Technical Specs :

    Ingredient(s) : Microcrystalline Cellulose Excipients

    Dosage Form : Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

    Ingredient(s) : Microcrystalline Cellulose Excipients

    Dosage Form : Tablet

    Category : Coating Systems & Additives, Controlled & Modified Release

    Brand : ACTILLETS™

    Applications : ACTILLETS are microcrystalline cellulose spheres developed using advanced drug delivery technology to enable effective loading & coating of particles.

    Pharmacopoeia Ref : NA

    Technical Specs : Not Available

    Grade : Oral

    arrow
    ACTILLETS™

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    02

    Nanjing Well Pharmaceutical

    China
    arrow
    CPhI WW Frankfurt
    Booth #12.1G60
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgel Capsule, Softgels

    Grade : Parenteral, Topical, Oral

    Brand Name : Polyethylene Glycol 400

    Application : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical

    Excipient Details : PEG 400 is used as a suspending agent, stabilizer, plasticizer and filler in OSDs, liquids & semi-solids and as a solvent for parenteral formulations.

    Pharmacopoeia Ref : ChP/USP/EP

    Technical Specs : NA

    Ingredient(s) : Polyethylene Glycol 400

    Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgel Capsule, Softgels

    Grade : Parenteral, Topical, Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Ingredient(s) : Polyethylene Glycol 400

    Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgel Capsule, Softgels

    Category : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical

    Brand : POLYETHYLENE GLYCOL 400

    Applications : PEG 400 is used as a suspending agent, stabilizer, plasticizer and filler in OSDs, liquids & semi-solids and as a solvent for parenteral formulations.

    Pharmacopoeia Ref : ChP/USP/EP

    Technical Specs : NA

    Grade : Parenteral, Topical, Oral

    arrow
    Nanjing Well Polyethylene Glycol 400 NF

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    03

    Nomisma Healthcare

    PLLA-PEG

    arrow
    Aus. Peptide Conference
    Not Confirmed

    04

    CD Formulation

    GLYCERYL MONOSTEARATE

    arrow
    Aus. Peptide Conference
    Not Confirmed

    CD Formulation

    U.S.A
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Cream / Lotion / Ointment, Tablet

    Grade :

    Brand Name : Glyceryl Monostearate

    Application : Controlled & Modified Release, Solubilizers, Thickeners and Stabilizers, Topical

    Excipient Details : Glyceryl monostearate is used as an emollient, solubilizer, stabilizer, emulsifier, and sustained-release agent in tablets and capsules.

    Pharmacopoeia Ref :

    Technical Specs :

    Ingredient(s) : Glyceryl Monostearate

    Dosage Form : Capsule, Cream / Lotion / Ointment, Tablet

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Glyceryl Monostearate

    Dosage Form : Capsule, Cream / Lotion / Ointment, Tablet

    Category : Controlled & Modified Release, Solubilizers, Thickeners and Stabilizers, Topical

    Brand : GLYCERYL MONOSTEARATE

    Applications : Glyceryl monostearate is used as an emollient, solubilizer, stabilizer, emulsifier, and sustained-release agent in tablets and capsules.

    Pharmacopoeia Ref : Not Available

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    05

    Nomisma Healthcare

    PLGA-PEG

    arrow
    Aus. Peptide Conference
    Not Confirmed

    Nomisma Healthcare

    India
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral, Parenteral

    Brand Name : PLGA-PEG

    Application : Controlled & Modified Release

    Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipient

    Dosage Form : Tablet

    Grade : Oral, Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipient

    Dosage Form : Tablet

    Category : Controlled & Modified Release

    Brand : PLGA-PEG

    Applications : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

    Grade : Oral, Parenteral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    06

    Finar

    POLYETHYLENE GLYCOL 400

    arrow
    Aus. Peptide Conference
    Not Confirmed

    07

    Ideal Cures

    ESPHERES EM

    arrow
    Aus. Peptide Conference
    Not Confirmed

    08

    Sigachi Industries

    HICEL MCC SPHERES

    arrow
    Aus. Peptide Conference
    Not Confirmed

    09

    Actylis

    POLYETHYLENE GLYCOL 400

    arrow
    Aus. Peptide Conference
    Not Confirmed

    10

    Actylis

    SODIUM CITRATE DIHYDRATE MULTI-COMPENDIAL

    arrow
    Aus. Peptide Conference
    Not Confirmed